1
Glover Francis James, Rushton Arthur, Young Stephen Clinton, Morgan Phillip John: Angiotensin derivatives. Proteus Molecular Design, December 15, 2004: EP1486505-A1

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


2
James Francis Glover, Arthur Rushton, Phillip John Morgan, Stephen Clinton Young: Angiotensin derivatives. Protherics Medicines Development, Bacon & Thomas PLLC, May 27, 2008: US07378489

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


3
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Derives dangiotensine, Angiotensin derivatives. Proteus Molecular Design, Proteus Molecular Design, Fetherstonhaugh & Co, December 15, 2009: CA2294996

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which canbe used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


4
James Francis Glover, Arthur Rushton, Phillip John Morgan, Stephen Clinton Young: Angiotensin derivatives. Protherics Medicines Development, Bacon & Thomas Pllc, April 23, 2009: US20090105150-A1

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


5
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Angiotensin derivatives. Proteus Molecular Design, Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton, GRANT Anne Rosemary, December 30, 1998: WO/1998/058952

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


6
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Angiotensin derivatives. Proteus Molecular Design, May 24, 2000: EP1001978-A1

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.